Gilead Sciences’ Kevin Young CBE, Executive Vice President, Commercial Operations, to Retire

10-01-2014 Business Wire HealthComments (0)

BiotechnologyGilead Sciences

Gilead Sciences, Inc. (Nasdaq:GILD) today announced that Kevin Young CBE, Executive Vice President, Commercial Operations, has informed the company of his decision to retire, effective February 4th. Mr. Young will continue to work directly with Gilead’s management team as a senior advisor. Mr. Young joined Gilead in 2004 to lead the company’s global commercial operations. During his tenure, he oversaw the launch of eight new therapies, including the first s

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top